Intestinal Microbiome Transplant in ALS | MicrobiomeTrials← Back to trialsNCT07017946
Intestinal Microbiome Transplant in ALS
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-01-27Est. Completion: 2026-11-01
Enrollment target: 20 participants Locations- Duke University Medical Center, Durham, North Carolina, United States
Other microbiome trials you might be interested in
Spinal Cord InjuryAmyotrophic Lateral SclerosisBrain Stem InfarctionsLocked-in SyndromeMuscular Dystrophy
VA research has been advancing a high-performance brain-computer interface (BCI) to improve independence for Veterans an…
Providence, United StatesEst. completion Jun 30, 2027
Amyotrophic Lateral Sclerosis (ALS)AutoantibodyPlasmapheresis
10-20% of patients with ALS have anti-NRIP autoantibody and the titer of anti-NRIP autoantibody is correlated with motor…
Taipei City, TaiwanEst. completion Jan 31, 2029
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositisPolymyositisImmune-Mediated Necrotizing MyopathyAntisynthetase Syndrome
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participant…
Phoenix, United StatesCompleted Jul 2, 2026